Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp.（EUCR）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · EUCR · 截至 Jun 9, 2026
关键指标
探索 Eucrates Biomedical Acquisition Corp. 数据
eucr stock data · financials财务快照
完整财报竞争对手与同行
eucr competitorsEUCR
ARTEU
BRACU
BYTSW
FMIV
FNVT股票表现
完整历史关于 Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity …
what is eucrates biomedical acquisition corp. · eucr stock overview · eucrates biomedical acquisition corp. company profile · who is eucrates biomedical acquisition corp. ceo · eucr NASDAQ · eucrates biomedical acquisition corp. headquarters · eucrates biomedical acquisition corp. business segments
关于股票概览与关键数据
Eucrates Biomedical Acquisition Corp.（EUCR）是 Shell Companies 行业的 Financial Services 类公司，于 Dec 28, 2020 在 NASDAQ 上市。截至最近交易日，EUCR 股价为 $10.04，市值约为 $42.2M。过去12个月累计回报 +1.62%，年初至今回报 +0.50%。
2022 财年 Eucrates Biomedical Acquisition Corp. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Eucrates Biomedical Acquisition Corp.（EUCR）股价为 $10.04，在 NASDAQ 上市，52周区间为 $9.87 – $10.25。